1[1]Schuller J,Cassidy J,Reigner B,et al.Tumor selective activation of capecitabine in co1orectal cancer patients [J].Oncologie,1997,20(supple 1):732.
2[2]Blum JL,Jones SE,Buzdar AU,et al.A multicenter phase Ⅱ study of capecitabine in paclitaxel-refraetory metastatic breast canter[J].J Clin Oncol,1999,17:485.
3[3]Moiseyenko V,O'Reilly SM,Talbot DC,et al.A randomized phase Ⅱ study of Xeloda(capecitabine)vs.paclitaxel in breast cancer patients failing previous anthracycline therapy[J].Ann Oncol,1998,9:13.
4[4]Shaughness J,Moiseyenko V,Bell D,et al.A Randomized phase Ⅱ study of Xeloda(capecitabine) vs.CMF as first line chemotherapy of breast cancer in women aged ≥ 55years[J].Proc Am Soc Clin Oncol,1998,17:103a.
5[5]Budman DR,Meropol NJ,Reigner B,et al.Preliminary studies of a novel fluoropyrimidine carbamate:Capecitabine[J].J Clin Oncol,1998,16:1795.
6[6]Cassidy J,Dirix L,Bissett D,et al.A phase Ⅰ study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors[J].Clin Cancer Res,1998,4:2755.
7Miwa M, Ura M, Nishida M, et o.1. Design of a novel oral fluoropyrimidine Carb amate, which generates 5 -fluorouracil selectively in tumors by enzymes concentrate in human liver and cancer tissucs[J]. Eur J Cancer,1998,34:1274 -1281.
8Gerbrecht B M. Current Canadian experlenee with capecitabine: part nering with patients to optimize therapy [ J ]. Cancer Nuts, 2003, 26 ( 2 ) :161 - 167.
9Rothenberg M L. Current status of capecitabine in the treatment of colo orectal cancer [J ]. Oneology (Hiuntingt), 2002, 16 (12) : 16 - 22.
10Eng C, Kindler H L, Sehilsky R L. Oral flμoropyrimidine treatment of colorectal cancer[] ]. Clin Colorectal Cancer, 2001, 1 (2): 95 - 103.
